The peptide hormone glucagon forms amyloid fibrils with two coexisting β-strand conformations
Glucagon and insulin maintain blood glucose homeostasis and are used to treat hypoglycemia and hyperglycemia, respectively, in patients with diabetes. Whereas insulin is stable for weeks in its solution formulation, glucagon fibrillizes rapidly at the acidic pH required for solubility and is therefo...
Main Authors: | Gelenter, Martin David, Liao, Shu-Yu, Mandala, Venkata Shiva, Dregni, Aurelio J., Hong, Mei |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2020
|
Online Access: | https://hdl.handle.net/1721.1/125383 |
Similar Items
-
Structurally Based Design of Glucagon Mutants That Inhibit Fibril Formation
by: Gelenter, Martin D, et al.
Published: (2022) -
Identification of a Novel Parallel β-Strand Conformation within Molecular Monolayer of Amyloid Peptide
by: Liu, Lei, et al.
Published: (2017) -
Hydration and Dynamics of Full-Length Tau Amyloid Fibrils Investigated by Solid-State Nuclear Magnetic Resonance
by: Dregni, Aurelio J, et al.
Published: (2022) -
In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments
by: Dregni, Aurelio J., et al.
Published: (2020) -
Transport-Relevant Protein Conformational Dynamics and Water Dynamics on Multiple Time Scales in an Archetypal Proton Channel: Insights from Solid-State NMR
by: Mandala, Venkata Shiva, et al.
Published: (2019)